Natco Pharma
₹974.00
+4.4 (0.45%)
13 May, 2024 07:07 BSE: 524816
NSE: NATCOPHARMISIN: INE987B01026
Start SIP in Natco Pharma
Start SIPNatco Pharma Performance
Day Range
- Low 964
- High 987
52 Week Range
- Low 609
- High 1,108
- Open Price970
- Previous Close970
- Volume277584
Natco Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 625 | 931 | 1,048 | 781 |
Operating Expenses Qtr Cr | 387 | 488 | 545 | 454 |
Operating Profit Qtr Cr | 238 | 442 | 504 | 328 |
Depreciation Qtr Cr | 40 | 40 | 40 | 38 |
Interest Qtr Cr | 4 | 3 | 3 | 1 |
Tax Qtr Cr | 32 | 64 | 70 | 52 |
Net Profit Qtr Cr | 192 | 360 | 405 | 254 |
Natco Pharma Technicals
EMA & SMA
Current Price
₹974.00
+4.4 (0.45%)
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹996.12
- 50 Day
- ₹977.06
- 100 Day
- ₹935.62
- 200 Day
- ₹870.34
- 20 Day
- ₹999.04
- 50 Day
- ₹988.35
- 100 Day
- ₹923.14
- 200 Day
- ₹874.67
Natco Pharma Resistance and Support
PIVOT
₹975.05
Resistance | |
---|---|
First Resistance | 985.80 |
Second Resistance | 997.60 |
Third Resistance | 1,008.35 |
RSI | 44.54 |
MFI | 57.32 |
MACD Single Line | 8.10 |
MACD | 2.05 |
Support | |
---|---|
First Resistance | 963.25 |
Second Resistance | 952.50 |
Third Resistance | 940.70 |
Natco Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 295,659 | 14,679,469 | 49.65 |
Week | 576,262 | 32,489,629 | 56.38 |
1 Month | 686,103 | 33,776,843 | 49.23 |
6 Month | 882,017 | 38,111,964 | 43.21 |
Natco Pharma Result Highlights
Natco Pharma Synopsis
NSE-Medical-Diversified
Natco Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2351.00 Cr. and Equity Capital is Rs. 36.50 Cr. for the Year ended 31/03/2023. Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201.Market Cap | 17,445 |
Sales | 3,385 |
Shares in Float | 8.96 |
No of funds | 320 |
Yield | 0.92 |
Book Value | 3.78 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | |
Alpha | 0.18 |
Beta | 0.62 |
Natco Pharma
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 49.71% | 49.71% | 49.71% | 49.76% |
Mutual Funds | 4.08% | 5.2% | 7.65% | 9.45% |
Insurance Companies | 5.58% | 6.04% | 6.34% | 5.57% |
Foreign Portfolio Investors | 16.14% | 13.72% | 12.82% | 11.03% |
Financial Institutions/ Banks | ||||
Individual Investors | 20.61% | 21.24% | 19.5% | 20.21% |
Others | 3.88% | 4.09% | 3.98% | 3.98% |
Natco Pharma Management
Name | Designation |
---|---|
Mr. G S Murthy | Chairman & Ind.Director |
Mr. V C Nannapaneni | Managing Director |
Mr. Rajeev Nannapaneni | Director & CEO |
Mr. T V Rao | Independent Director |
Mr. D G Prasad | Independent Director |
Dr. M U R Naidu | Independent Director |
Dr. Leela Digumarti | Independent Director |
Mr. P S R K Prasad | Director & Exe. VP (Corp. Engg. Services) |
Dr. Linga Rao Donthineni | Director & President (Tech. Affairs) |
Dr. Pavan Ganapati Bhat | Director |
Natco Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Natco Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-27 | Audited Results | |
2024-02-14 | Quarterly Results & Interim Dividend | |
2023-11-14 | Quarterly Results & Interim Dividend | |
2023-08-09 | Quarterly Results & Interim Dividend | |
2023-05-29 | Audited Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-26 | INTERIM | Rs.1.25 per share(62.5%)Third Interim Dividend |
2023-11-24 | INTERIM | Rs.1.25 per share(62.5%)Second Interim Dividend |
2023-08-22 | INTERIM | Rs.7.00 per share(350%)Interim Dividend |
2023-02-21 | INTERIM | Rs.1.25 per share (62.5%) Third Interim Dividend |
2022-11-22 | INTERIM | Re.0.75 per share (37.50%) Second Interim Dividend |
Natco Pharma FAQs
What is Share Price of Natco Pharma ?
Natco Pharma share price is ₹974 As on 13 May, 2024 | 06:53
What is the Market Cap of Natco Pharma ?
The Market Cap of Natco Pharma is ₹17445.3 Cr As on 13 May, 2024 | 06:53
What is the P/E ratio of Natco Pharma ?
The P/E ratio of Natco Pharma is 13.7 As on 13 May, 2024 | 06:53
What is the PB ratio of Natco Pharma ?
The PB ratio of Natco Pharma is 3.6 As on 13 May, 2024 | 06:53